Health and Environment Training Classes

Overview: Understanding TIR 45 can be the roadmap for improving development and benefiting everyone, companies, development teams, caregivers, patients, and regulators. Why should you Attend: Perhaps you're a development manager, hoping to improve both productivity and quality. Or you are a quality assurance manager, facing a demand from management and development to permit a move to Agile.

Overview: Use of analytical methods is widespread. However, there are no formally accepted guideline or formats for the overall process of design, development, optimization & validation of analytical methods. Why should you Attend: Method validation is the process of demonstrating that analytical procedures are suitable for their intended use and that they support the identity, strength, quality, purity and potency of the drug substances and drug or other products.

This webinar explains the inter-connected Breach Notification Rule requirements of Covered Entities and Business Associates when a Business Associate or Subcontractor Business Associate suffers a Breach. And it covers the special, more restrictive compliance requirements when a Business Associate or Subcontractor is an Agent under the Federal Common Law of Agency - including how to avoid creating an agency relationship by mistake.Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://onlinecompliancepanel.com/webinar/HIPAA-REACH-NOTIFICATION-FOR-COVERED-ENTITIES-AND-BUSINESS-ASSOCIATES-505808/OCTOBER-2017-ES-TRAININGREGISTRY

OSHA requires that businesses maintain a running account of injuries and illness that occur in the workplace. The logs must be completely and accurately filled in and completed. At the end of the year, these figures must be reported to OSHA or other report collection agencies to determine if the rate of injuries and illnesses falls within the norm for that industry sector.Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://www.onlinecompliancepanel.com/webinar/OSHA-RECORDKEEPING-COMPLIANCE-THE-NUTS-AND-BOLTS-OF-COMPLETING-THE-OSHA-300-Log-502949/OCTOBER-2017-ES-TRAININGREGISTRY

Before performing any healthcare act, it is important to understand and identify the possible risks. Once we understand and identify what the risks are, healthcare providers need to decide on their response to that risk and the different scenarios they may be faced with. This has to be done before any harm is done to patients. Two methods of doing this are the Failure Mode and Effects Analysis (FMEA) and Fault Tree Analysis (FTA).Price:$200.00. Contact info : OnlineCompliancePanel Phn. no. +1-510-857-5896 Fax-+1-510-509-9659 info@onlinecompliancepanel.com Event link https://www.onlinecompliancepanel.com/webinar/FMEA-AND-FAULT-TREE-ANALYSIS-FOR-PREVENTING-HOSPITAL-RISKS-505276/OCTOBER-2017-ES-TRAININGREGISTRY

The Omnibus Rule finalizes the modifications to the HIPAA Privacy Rule, Security Rule, and enforcement rules to implement many of the privacy, security, and enforcement provisions of the HITECH Act and to make other changes to the Rules, modifies the breach notification rule, and finalizes the modifications to the HIPAA Privacy Rule to strengthen privacy protections for genetic information. Generally speaking, covered entities and business associates will have until September 23, 2013, to comply with these new provisions. This 60-minute webinar gives you an excellent overview of the new rule changes. Learn what actions to take now to achieve HIPAA compliance with the new Omnibus Rule, to pass an audit or an investigation, and to avoid civil money penalties and criminal convictions.

This webinar focuses on HIPAA Rules for transmitting informational email and text messages to patients over an electronic communications network. You will learn: The information that makes a message subject to HIPAA The "safe harbor" - How Health Care Providers may obtain consent from patients to send PHI in unencrypted email and unencrypted text messages and not be responsible for unauthorized access to the PHI in transmission or when received by the patient What a Health Care Provider must do if a patient does not agree to receive PHI in unencrypted email or unencrypted text message The requirements for a Business Associate to be able to communicate by email or text message with a patient on behalf of a Health Care Provider How a Business Associate may protect itself from liability for violating HIPAA Rules about email and text messages in its Business Associate Agreement

This session is designed to provide intensive, two-day training in HIPAA compliance, including what's new in the regulations, what's changed recently, and what needs to be addressed for compliance by covered entities and business associates. The session provides the background and details for any manager of healthcare information privacy and security to know what are the most important privacy and security issues, what needs to be done for HIPAA compliance, and what can happen when compliance is not adequate. Audits and enforcement will be explained, as well as privacy and security breaches and how to prevent them. Numerous references and sample documents will be provided. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901357SEMINAR?trainingregistry-November-2017-SEO

If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue. Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments must collaborate to avoid the hammer and penalties of FDA. The roadblock, however is that marketing managers and regulatory affairs managers rarely reach common ground and are loathe to even consult with each other. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901102SEMINAR?trainingregistry-November-2017-SEO

Testing is the science of identifying defects, so that they can be corrected, and of demonstrating that a system meets intended requirements. Testing computerized systems is considered a fundamental verification activity and appropriate testing is a regulatory expectation as described in many regulations e.g. EU GMP Annex 11. "Evidence of appropriate testing methods and test scenarios should be demonstrated. Particularly system (process) parameter limits, data limits and error handling should be considered" The regulated company is responsible for demonstrating compliance and fitness for use. Effective testing demonstrates compliance with regulatory requirements and ensures patient safety, product quality and data integrity as a result of controlling identified risks. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901360SEMINAR?trainingregistry-November-2017-SEO

Being in compliance with HIPAA involves not only ensuring that you provide the appropriate patient rights and controls on your uses and disclosures of Protected Health Information; but that you also have the proper policies and procedures in place. If audited or the subject of a compliance review, you will be required to show the government you have all the necessary documentation in place for safeguarding patient Protected Health Information and indicate how you addressed all required security safeguards. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901282SEMINAR?trainingregistry-November-2017-SEO

This 2-day seminar will cover the essentials of compliance for medical device companies. An efficient and effective quality system can be a competitive advantage for companies by leading to improved quality and compliance as well as optimizing the cost of quality. This "Compliance Boot Camp" will get you started in setting up just such a Quality System. We'll discuss the "case for quality" and how you can use compliance, not as an end itself, but as a means to improved quality and reduced cost of non-compliance. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901152SEMINAR?trainingregistry-November-2017-SEO

The final version of ISO 13485:2016 is now available and companies should be planning their implementation. There are significant changes from the earlier version; they will require major modifications to the Quality Management System (QMS). The new version has better alignment with FDA's QSR, but there are still major differences that create issues for effective QMS implementation. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901112SEMINAR?trainingregistry-November-2017-SEO

This course will present the procedures that must be used in the application of DOE and SPC to the development, design and monitoring of manufacturing and testing processes. A practical approach with case studies and examples will be used, with theoretical information introduced only when necessary to understand an experiment. Examples from real processes and testing procedures will be used to present the student with examples that will be directly applicable to their work. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901327SEMINAR?trainingregistry-November-2017-SEO

This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901321SEMINAR?trainingregistry-November-2017-SEO

Supplier selection and management is one of the critical issues for medical device manufacturers. Suppliers provide materials and services to the device manufacturer, which means that they can be critical to performance and delivery of your device. Neither the FDA nor your notified body regulates your suppliers (with a few exceptions). They expect you to have an effective process to ensure your suppliers perform in the regulatory environment. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901162SEMINAR?trainingregistry-November-2017-SEO

Complaint handling is likely one of the more cross-functional parts of your quality system: Customer Service may receive your customer complaints, Sales and Marketing may need to reach out to the customer for additional information, Regulatory Affairs may determine whether the complaint is reportable, QA may perform the root cause investigation, R&D or Manufacturing Engineering may need to be involved in the corrective action, and Quality Engineering may need to trend the complaints! Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901336SEMINAR?trainingregistry-November-2017-SEO

The Webinar will focus on the importance of ensuring that electronic record/electronic signature (ER/ES) capability built into FDA-regulated computer systems meets compliance with 21 CFR Part 11. This includes development of a company philosophy and approach, and incorporating it into the overall computer system validation program and plans for individual systems that have this capability. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901297SEMINAR?trainingregistry-November-2017-SEO

An essential task in any compliance analytics workflow is to not only explore your data visually, but also to communicate your results professionally with graphic displays. Do you have the tools and skills to quickly and thoroughly perform these tasks? This course in data visualization will present methods to allow you to interactively discover relationships graphically. We will provide the foundations for creating better graphical information to accelerate the insight discovery process and enhance the understandability Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901116SEMINAR?trainingregistry-November-2017-SEO

This course will present, in one place, the regulations and guidelines that apply to early phase products. In some cases these will not be regulations, but needs that, if met, will increase the efficiency of activities as a product proceeds through the development process. The course will present these items in the order of product development from the point of R & D activities to the completion of Phase 2 clinical trials. Read More: http://www.globalcompliancepanel.com/control/globalseminars/~product_id=901318SEMINAR?trainingregistry-November-2017-SEO